Dr Abhithaj J
Assistant Professor (Grade-II)
| Center for Integrative Omics Data Science (CIODS)
Yenepoya (deemed to be University), Mangalore
Karnataka
Expertise:
Biochemistry and Molecular Biology
37
Publications
0
Projects
193
Scopus Citations
254
CrossRef
14 Years 3 Months Total Experience
Scopus
193
Citations
8
h-index
CrossRef
254
Citations
7
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Best faculty researcher award - 2026
2026
Yenepoya (Deemed to be University)
Community & Membership
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Personal Details
Doctor of Philosophy
2021
Gnanamani College of Engineering
Assistant Professor (Grade-II)
Oct 2024 – Present
Yenepoya (deemed to be University), Mangalore
| Center for Integrative Omics Data Science (CIODS)
Research Associate
Jun 2022 – Oct 2024
Kannur University, Kannur
Assistant Professor
Jan 2022 – May 2022
Kannur University, Kannur
Senior Research Fellow
Jun 2018 – Jun 2021
Kannur University, Kannur
Project Fellow
Dec 2016 – Mar 2018
Kannur University, Kannur
Assistant Professor
Jun 2010 – Nov 2014
MHES COLLEGE OF SCIENCE & TECHNOLOGY, MANIYOOR
Project Fellow
Aug 2009 – Mar 2010
University of Kerala, Thiruvananthapuram
Medical and Health Sciences
Scholarly Work
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Scholarly Publications
Design, synthesis and biological evaluation of tacrine-sulphonamide hybrids as a potent acetylcholinesterase inhibitor
Open AccessComputational Tools in Drug-Lead Identification and Development
10.1007/978-981-99-9183-9_4
Crossref: 5
Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis
Open AccessCOVID-19 Omicron variant-inhibitory in silico evidence for phytocompounds of an ancient Ayurvedic formulation
Open AccessDrug Repurposing for COVID-19 from FDA Approved and Experiment Stage Drugs by in Silico Methods with SARS CoV-2 Spike Protein
Open Access
10.26434/chemrxiv.12324980.v1
Crossref: 3
Drug repurposing to identify therapeutics against COVID 19 with SARS-Cov-2 spike glycoprotein and main protease as targets: an in silico study
Open Access
10.26434/chemrxiv.12090408.v1
Crossref: 3
Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and in vitro studies
Isozymes inhibited by active site blocking: versatility of calcium indifferent hesperidin binding to phospholipase A<sub>2</sub> and its significance
Showing 1 to 8 of 37 publications